Oramed Pharmaceuticals Inc. (ORMP): Operating Cash Flow
-$9.14M
Year ended 2025-12-31
-$5.21M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.14M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$8.41M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$10.29M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$27.92M | n/a | 2024-03-06, From 2022-01-01 |
| No annual figure between 2021-08-31 and 2022-12-31. | |||
| 2021-08-31 | -$21.18M | n/m | 2023-03-06, From 2020-09-01 |
| 2020-08-31 | -$12.44M | n/m | 2021-11-24, From 2019-09-01 |
| 2019-08-31 | -$12.94M | n/m | 2020-11-24, From 2018-09-01 |
| 2018-08-31 | -$14.66M | n/m | 2019-11-27, From 2017-09-01 |
| 2017-08-31 | -$5.83M | n/m | 2019-11-27, From 2016-09-01 |
| 2016-08-31 | $4.66M | n/m | 2018-11-28, From 2015-09-01 |
| 2015-08-31 | -$4.95M | n/m | 2017-11-29, From 2014-09-01 |
| 2014-08-31 | -$4.07M | n/m | 2016-11-25, From 2013-09-01 |
| 2013-08-31 | -$3.40M | n/m | 2015-11-25, From 2012-09-01 |
| 2012-08-31 | -$2.30M | n/m | 2014-11-14, From 2011-09-01 |
| 2011-08-31 | -$1.71M | n/a | 2012-12-12, From 2010-09-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | 2025-12-31 | -$9.14M | n/m |
| Immuneering Corp (IMRX) | 2025-12-31 | -$45.34M | n/m |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | -$54.36M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$42.27M | n/m |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | -$128.34M | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$76.44M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$206.0K | n/m |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | -$71.53M | n/m |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | -$76.33M | n/m |
Compare ORMP, IMRX, DSGN, EOLS side by side · Screen every company in Pharmaceutical Preparations ↗